Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07651956 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Sep 2026 to Nov 25, 2026v3
  2. Start date: Jun 2026 to Sep 2026v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients presenting for a scheduled cesarean delivery who require a neuraxial anesthetic will be randomized to receive intravenous remimazolam or dexmedetomidine for procedural sedation during the placement of their spinal or epidural anesthesia.
Trial Details
NCT Number NCT07651956
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions
(from sponsor)		 Pregnant People, Anxiety
Related terms Anxiety Disorders
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov